Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Blood Collection Study From Volunteers Who Have Recovered From COVID-19 Infection to Identify Immunogenic Viral Epitopes in SARS-CoV-2

NCT04397900 is registered in ClinicalTrials.gov with TScan Therapeutics, Inc. as lead sponsor.

NCT NCT04397900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Blood Collection Study From Volunteers Who Have Recovered From COVID-19 Infection to Identify Immunogenic Viral Epitopes in SARS-CoV-2
Lead sponsor
TScan Therapeutics, Inc.
Phase
Observational
Overall status
Completed
Start date
April 9, 2020
Completion date
April 12, 2021
Enrollment
80 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

determine which sars-cov-2 proteins are frequently recognized by t cells in patients with varying hla types, identify the viral epitopes of memory cd8 t cells from individuals that have recovered from sars-cov-2 infection